Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis-B antibody in polymyalgia Rheumatica.

P A Bacon, S M Doherty, A J Zuckerman

    Lancet (London, England)
    |September 13, 1975
    PubMed
    Summary

    Polymyalgia rheumatica (P.M.R.) patients frequently show hepatitis B antibodies, suggesting a viral trigger. Steroid treatment altered immunoglobulin levels, indicating an abnormal immune response in elderly patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Selected Sumaries.

    Acta clinica Belgica·2016
    Same author

    Viral hepatitis and haemophilia: an introduction.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Trials of Live Influenza Vaccine in the Royal Air Force.

    British medical journal·2010
    Same author

    ABO Blood Groups and Acute Respiratory Virus Disease.

    British medical journal·2010
    Same author

    Acute hepatitis.

    British medical journal·2010
    Same author

    Coe (Coxsackie A 21) virus, para-influenza virus and other respiratory virus infections in the R.A.F., 1958-60.

    The Journal of hygiene·2010

    Area of Science:

    • Immunology
    • Virology
    • Rheumatology

    Background:

    • Polymyalgia rheumatica (P.M.R.) is an inflammatory condition primarily affecting the elderly.
    • The etiology of P.M.R. remains unclear, with potential links to infectious agents.
    • Giant-cell arteritis often co-occurs with P.M.R., suggesting shared underlying mechanisms.

    Purpose of the Study:

    • To investigate the potential role of viral infections, specifically Hepatitis B, in the pathogenesis of P.M.R.
    • To examine the immunological profile of P.M.R. patients, including antibody levels and immunoglobulins.
    • To assess changes in immunoglobulin levels during corticosteroid therapy.

    Main Methods:

    • Serological testing for Hepatitis-B surface antibody (HBsAb) and Hepatitis-B surface antigen in P.M.R. patients and age-matched controls.
    • Antibody titre analysis for a panel of twelve other common organisms.
    • Serial measurement of immunoglobulin (IgG, IgA, IgM) levels before and during steroid treatment.

    Main Results:

    • HBsAb was detected in 9 out of 12 P.M.R. patients pre-treatment, significantly higher than in controls (1 out of 12).
    • HBsAb persisted in 4 patients for up to six months.
    • Elevated baseline immunoglobulin levels were observed in several patients, with steroid therapy leading to decreased IgG/IgA and increased IgM levels in some.

    Conclusions:

    • Hepatitis B infection is a potential trigger for polymyalgia rheumatica.
    • P.M.R. may represent an aberrant immunological response to infection in elderly individuals.
    • The observed immunoglobulin changes suggest a complex immune dysregulation in P.M.R.

    Related Experiment Videos